Why Biotech Struggles to Finish What It Starts Summary: Researchers use artificial intelligence to rapidly design potent antibodies that can both block and activate G protein-coupled receptors, revolutionizing drug development.Biotech doesn’t typically fail in the lab. It fails later — after early promise and before approval — when the cost of proving a drug works […]